A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate, Cefazolin, Ciprofloxacin, Clopidogrel10

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	6 mg	IV	not captured	standing	pages 44, 228
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 150
Other	peds	0.3 mg	IV/IO	not captured	standing	page 286
Other	peds	0.4 mg	IV/IO	not captured	standing	page 286
Other	peds	0.5 mg	IV/IO	not captured	standing	page 286
Other	peds	0.65 mg	IV/IO	not captured	standing	page 286
Other	peds	0.85 mg	IV/IO	not captured	standing	page 287
Other	peds	1 mg	IV/IO	not captured	standing	page 287
Other	peds	1.3 mg	IV/IO	not captured	standing	page 288
Other	peds	1.65 mg	IV/IO	not captured	standing	page 288
Other	peds	2.1 mg	IV/IO	not captured	standing	page 289
Other	peds	2.65 mg	IV/IO	not captured	standing	page 289
Other	peds	3.3 mg	IV/IO	not captured	standing	page 290
SVT	adult	6 mg	IV	not captured	standing	pages 44, 45, 150, 228
SVT	adult	6 mg	IV	not captured	standing	page 228
SVT	peds	0.1 mg/kg	IV	not captured	standing	page 228
SVT	peds	0.1 mg/kg	IV	not captured	standing	pages 44, 45, 150, 228

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	2.5 mg	NEB	not captured	standing	pages 34, 142, 229
Anaphylaxis	peds	2.5 mg	NEB	not captured	standing	pages 34, 142, 229
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 28, 29, 136, 229
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 28, 29, 136, 229
COPD	adult	2.5 mg	NEB	not captured	standing	pages 28, 29, 229
Hyperkalemia	adult	10 mg	NEB	not captured	standing	pages 76, 168, 229
Other	adult	2.5 mg	NEB	not captured	standing	pages 22, 229
Other	adult	2.5 mg	NEB	not captured	standing	pages 22, 229
Other	adult	2.5 mg	NEB	not captured	standing	pages 34, 142, 229
Other	peds	2.5 mg	NEB	not captured	standing	pages 34, 142, 229

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	15 mg	IV/IO	not captured	standing	page 286
Other	peds	20 mg	IV/IO	not captured	standing	page 286
Other	peds	25 mg	IV/IO	not captured	standing	page 286
Other	peds	32 mg	IV/IO	not captured	standing	page 286
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 46, 156, 231
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 46, 156, 231
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 54, 56, 58, 154, 231
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 54, 56, 58, 154, 231
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 54, 56, 58, 154, 231
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 54, 56, 58, 154, 231
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 54, 56, 58, 154, 231
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 54, 56, 58, 154, 231

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	324 mg	PO	not captured	standing	pages 40, 41, 232
Other	adult	324 mg	PO	not captured	standing	pages 40, 41, 232
Other	adult	324 mg	not captured	not captured	standing	page 232
Other	adult	324 mg	not captured	not captured	standing	pages 40, 41

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV/IO	not captured	standing	page 233
Nerve agent exposure	adult	2 mg	IV	not captured	standing	page 364
Organophosphate poisoning	adult	1 mg	IV	not captured	standing	pages 94, 148, 233
Organophosphate poisoning	peds	0.05 mg/kg	IV	not captured	standing	pages 94, 148, 233
Other	adult	1 mg	IV/IO	not captured	standing	pages 42, 148, 233
Other	adult	2 mg	IV/IM	not captured	standing	page 364
Other	adult	2 mg	IM	not captured	standing	page 365
Other	adult	2.1 mg	IM	not captured	standing	pages 279, 365
Other	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 42, 148, 233
Other	peds	0.26 mg	IV/IO	not captured	standing	page 288
Other	peds	0.33 mg	IV/IO	not captured	standing	page 288

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV/IO	not captured	standing	pages 96, 184, 234
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	pages 96, 184, 234
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 76, 168, 234
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 76, 168, 234
Other	adult	1 g	IV/IO	not captured	standing	pages 52, 54, 234
Other	adult	1 g	IV/IO	not captured	standing	pages 52, 54
Other	adult	1 g	IV/IO	not captured	standing	pages 96, 184
Other	adult	1 g	IV/IO	not captured	standing	page 234
Other	adult	1 g	IV/IO	not captured	standing	page 76
Other	peds	170 mg	IV/IO	not captured	standing	page 287
Other	peds	20 mg/kg	IV/IO	not captured	standing	pages 96, 184
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 234
Other	peds	210 mg	IV/IO	not captured	standing	page 287
Other	peds	260 mg	IV/IO	not captured	standing	page 288
Other	peds	330 mg	IV/IO	not captured	standing	page 288

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	3 g	IV/IO	not captured	standing	pages 96, 184
Beta-blocker / calcium-channel-blocker overdose	peds	60 mg/kg	IV/IO	not captured	standing	pages 96, 184
Hyperkalemia	adult	3 g	IV/IO	not captured	standing	pages 76, 168
Hyperkalemia	peds	60 mg/kg	IV/IO	not captured	standing	pages 76, 168
Other	adult	0.1–0.2 mL/kg	IV	not captured	standing	pages 102, 274
Other	adult	0.1–0.2 mL/kg	IV	not captured	standing	pages 102, 274
Other	adult	3 g	IV/IO	not captured	standing	pages 52, 54, 76, 146, 168
Other	adult	3 g	IV/IO	not captured	standing	page 52
Other	peds	60 mg/kg	IV/IO	not captured	standing	pages 52, 54, 76, 146, 168

Cefazolin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV/IO	not captured	standing	pages 118, 200, 235
Other	peds	1 g	IV/IO	not captured	standing	pages 118, 200, 235
Other	peds	1 g	IV/IO	not captured	standing	pages 200, 235

Ciprofloxacin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	400 mg	IV/IO	not captured	standing	page 276
Other	adult	500 mg	PO	not captured	standing	page 276

Clopidogrel

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	600 mg	PO	not captured	standing	page 277

D–F Dextrose, Diazepam, Diphenhydramine, Doxycycline, Droperidol, Epinephrine, Etomidate, Fentanyl8

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV/IO	not captured	standing	pages 72, 146, 166, 236
Hypoglycemia	peds	10.5 g	IV/IO	not captured	standing	page 289
Hypoglycemia	peds	12.5 g	IV/IO	not captured	standing	page 289
Hypoglycemia	peds	4.25 g	IV/IO	not captured	standing	page 287
Hypoglycemia	peds	5 mL/kg	IV/IO	not captured	standing	pages 72, 146, 166, 236
Hypoglycemia	peds	5.25 g	IV/IO	not captured	standing	page 287
Hypoglycemia	peds	6.5 g	IV/IO	not captured	standing	page 288
Hypoglycemia	peds	8.5 g	IV/IO	not captured	standing	page 288
Other	adult	12.5 g	IV/IO	not captured	standing	pages 94, 236
Other	adult	12.5 g	IV/IO	not captured	standing	pages 72, 236
Other	adult	25 g	IV/IO	not captured	standing	pages 72, 236
Other	peds	2 mL/kg	IV/IO	not captured	standing	pages 146, 166, 236

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	IM	not captured	standing	pages 279, 364, 365
Other	adult	2.5–5 mg	IV/IO	not captured	standing	pages 237, 251
Other	adult	2.5–5 mg	IV/IO	not captured	standing	page 237
Other	adult	2.5–5 mg	IV/IO	not captured	standing	pages 237, 251
Status epilepticus	adult	2.5–5 mg	IV/IO	not captured	standing	pages 237, 251
Status epilepticus	peds	0.15–0.2 mg/kg	IV/IO	not captured	standing	pages 237, 251

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	25–50 mg	IV/IM	not captured	standing	pages 164, 238
Agitation	peds	1 mg/kg	IV/IM	not captured	standing	pages 164, 238
Allergic reaction	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 34, 142, 238
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 34, 142, 238
Dystonic reaction	adult	25–50 mg	IV/IM	not captured	standing	pages 70, 238, 243, 254
Other	adult	25–50 mg	IV/IM	not captured	standing	pages 84, 238
Other	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 34, 142, 238
Other	adult	25–50 mg	IV/IM	not captured	standing	pages 70, 164, 238, 239, 243, 254
Other	adult	25–50 mg	IV/IM	not captured	standing	pages 84, 238
Other	adult	50 mg	IV/IO/IM	not captured	standing	pages 34, 142, 238
Other	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 34, 142, 238
Other	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 34, 142, 238
Other	peds	1 mg/kg	IV/IM	not captured	standing	pages 70, 164, 238, 239, 243, 254
Other	peds	1 mg/kg	IO	not captured	standing	pages 164, 238

Doxycycline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	PO	not captured	standing	page 278
Other	adult	100 mg	PO	not captured	standing	page 278

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IM	not captured	standing	pages 70, 239, 243
Other	adult	5 mg	IM	not captured	standing	pages 239, 243
Other	adult	5 mg	IM	not captured	standing	pages 70, 239

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3–0.5 mg	IM	not captured	standing	pages 34, 142, 240
Anaphylaxis	adult	100 mcg	IV/IO	not captured	standing	pages 34, 142, 240
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 34, 142, 240
Anaphylaxis	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 34, 142, 240
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 52, 54, 56, 146, 154, 240
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 52, 54, 56, 146, 154, 240
Other	adult	0.3–0.5 mg	IM	not captured	standing	pages 28, 29, 240
Other	adult	100 mcg	IV/IO	not captured	standing	pages 34, 240
Other	peds	0.01 mg/kg	IM	not captured	standing	page 240
Other	peds	0.01 mg/kg	IM	not captured	standing	pages 142, 240
Other	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 52, 146, 154, 240
Other	peds	3 mL	NEB	not captured	standing	pages 28, 240
Respiratory distress	adult	0.3–0.5 mg	IM	not captured	standing	pages 28, 29, 240
Respiratory distress	peds	0.01 mg/kg	IM	not captured	standing	pages 28, 29, 240
Stridor	adult	5 mg	NEB	not captured	standing	pages 28, 240
Stridor	peds	3–5 mL	NEB	not captured	standing	pages 28, 240

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.3 mg/kg	IV/IO	not captured	standing	page 280

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mcg/kg	IV/IO	not captured	standing	page 26
Other	adult	100 mcg	IV/IO/IM/IN	not captured	standing	page 241
Other	adult	25–100 mcg	IV/IO/IM/IN	not captured	standing	pages 20, 26, 40, 86, 176, 241
Other	adult	25 mcg	IV	not captured	standing	pages 20, 26, 241
Other	adult	25 mcg	IV/IO	not captured	standing	page 20
Other	adult	25 mcg	IV/IO/IM/IN	not captured	standing	page 241
Other	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 20, 26, 40, 86, 176, 241
Other	peds	10.5 mcg	IV/IM/IN	not captured	standing	page 287
Other	peds	13 mcg	IV/IM/IN	not captured	standing	page 288
Other	peds	16.5 mcg	IV/IM/IN	not captured	standing	page 288
Other	peds	21 mcg	IV/IM/IN	not captured	standing	page 289
Other	peds	26.5 mcg	IV/IM/IN	not captured	standing	page 289
Other	peds	3 mcg	IV/IM/IN	not captured	standing	page 286
Other	peds	4 mcg	IV/IM/IN	not captured	standing	page 286
Other	peds	5 mcg	IV/IM/IN	not captured	standing	page 286
Other	peds	6.5 mcg	IV/IM/IN	not captured	standing	page 286
Other	peds	8.5 mcg	IV/IM/IN	not captured	standing	page 287

G–L Glucagon, Haloperidol, Heparin, Hydromorphone, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam11

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 72, 166, 242
Other	peds	1 mg	IM	not captured	standing	page 166

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IM	not captured	standing	pages 70, 243
Other	adult	5 mg	IM	not captured	standing	pages 70, 243
Other	adult	5 mg	IM	not captured	standing	pages 70, 243

Heparin

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	60 unit/kg	IV/IO	not captured	standing	pages 40, 244

Hydromorphone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5–1 mg	IV/IM	not captured	standing	pages 86, 245
Other	adult	0.5–1 mg	IV/IO/IM	not captured	standing	page 86
Other	adult	0.5 mg	IV/IM	not captured	standing	page 245
Mild to moderate pain	adult	0.5–1 mg	IV/IM	not captured	standing	pages 86, 245

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 281
Other	adult	5 g	IV	not captured	standing	pages 98, 281

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.5 mg	NEB	not captured	standing	pages 34, 142, 230, 246
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	pages 28, 136, 230, 246
COPD	adult	0.5 mg	NEB	not captured	standing	pages 28, 230, 246
Other	adult	0.5 mg	NEB	not captured	standing	pages 22, 230, 246

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–2 mg/kg	IV/IO	not captured	standing	pages 26, 247
Other	adult	1–2 mg/kg	IV/IO	not captured	standing	pages 26, 247
Other	adult	1 mg/kg	IV/IO	not captured	standing	pages 20, 247
Other	adult	1 mg/kg	IV/IO	not captured	standing	page 20
Other	adult	1 mg/kg	IV/IO	not captured	standing	page 26
Other	adult	100 mg	IM/IN	not captured	standing	page 247
Other	adult	100 mg	IV/IO/IM	not captured	standing	pages 88, 247
Other	peds	2 mg/kg	IM	not captured	standing	pages 70, 164, 247
Other	peds	2 mg/kg	IM	not captured	standing	pages 70, 164, 247
Mild to moderate pain	adult	10 mg	IV/IO/IM/IN	not captured	standing	pages 86, 176, 247
Post-intubation sedation	adult	1 mg/kg	IV/IO	not captured	standing	pages 26, 247
Seizure	adult	100 mg	IV/IO/IM	not captured	standing	pages 88, 247

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	15 mg	IV/IO	not captured	standing	pages 86, 248
Other	adult	30 mg	IM	not captured	standing	pages 86, 248

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	IV	not captured	standing	pages 90, 249
Other	adult	10 mg	IV	not captured	standing	page 90
Other	adult	20 mg	IV	not captured	standing	pages 216, 249

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–1.5 mg/kg	IV/IO	not captured	standing	page 250
Other	adult	40 mg	IO	not captured	standing	page 250
Other	peds	0.5 mg/kg	IO	not captured	standing	page 250
Other	peds	1 mg/kg	IV/IO	not captured	standing	page 250
Other	peds	13 mg	IV/IO	not captured	standing	page 288
Other	peds	0.66 mL	IO	not captured	standing	page 289
Other	peds	21 mg	IV/IO	not captured	standing	page 289
Other	peds	1.32 mL	IV/IO	not captured	standing	page 289
Other	peds	4.25 mg	IO	not captured	standing	page 287
Other	peds	5.25 mg	IO	not captured	standing	page 287
Other	peds	8.25 mg	IO	not captured	standing	page 288
Other	peds	8.5 mg	IV/IO	not captured	standing	page 287
Wide-complex tachycardia	adult	1–1.5 mg/kg	IV/IO	not captured	standing	page 250
Wide-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	page 250
VF / pulseless VT	adult	1–1.5 mg/kg	IV/IO	not captured	standing	page 250
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	page 250

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Alcohol withdrawal	adult	1–2 mg	IV/IO/IM/IN	not captured	standing	page 251
Other	adult	1–2 mg	IV/IO/IM/IN	not captured	standing	page 251
Other	adult	1–2 mg	IV/IO/IM/IN	not captured	standing	page 251
Other	adult	1–2 mg	IV/IO/IM/IN	not captured	standing	page 251
Other	adult	1–2 mg	IV/IO/IM/IN	not captured	standing	page 251
Other	adult	1–2 mg	IV/IO/IM/IN	not captured	standing	page 20
Other	adult	1–2 mg	IV/IO/IM/IN	not captured	standing	pages 94, 182
Other	peds	0.05–0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 251
Other	peds	0.05–0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 94, 182
Other	peds	0.05 mg/kg	IV/IO/IM/IN	not captured	standing	page 251
Other	peds	0.65 mg	IV/IO	not captured	standing	page 288
Other	peds	0.825 mg	IV/IO	not captured	standing	page 288
RSI induction	adult	1–2 mg	IV/IO/IM/IN	not captured	standing	page 251
Status epilepticus	adult	1–4 mg	IV/IO/IM/IN	not captured	standing	page 251
Status epilepticus	peds	0.05–0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 251

M–O Magnesium Sulfate, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Olanzapine, Ondansetron, Oral Glucose, Oxytocin12

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	4 g	IV/IO	not captured	standing	page 252
Other	adult	2 g	IV/IO	not captured	standing	page 252
Other	adult	2 g	IV/IO	not captured	standing	page 252
Other	adult	2 g	IV/IO	not captured	standing	page 252
Other	adult	2 g	IV/IO	not captured	standing	page 252
Other	adult	2 g	IV/IO	not captured	standing	page 58
Other	adult	2 g	IV	not captured	standing	page 28
Other	adult	4 g	IV/IO	not captured	standing	page 252
Other	adult	4 g	IV/IO	not captured	standing	pages 216, 252
Other	peds	25 mg/kg	IV/IO	not captured	standing	pages 184, 252
Other	peds	25 mg/kg	IV/IO	not captured	standing	page 252
Other	peds	50 mg/kg	IV/IO	not captured	standing	page 252

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	125 mg	IV/IO/IM	not captured	standing	page 253
Anaphylaxis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 253
Other	adult	125 mg	IV/IO/IM/PO	not captured	standing	page 253
Other	adult	125 mg	IV/IO/IM/PO	not captured	standing	page 253
Other	adult	125 mg	IV/IO/IM/PO	not captured	standing	pages 28, 253
Other	adult	125 mg	IV/IO/IM	not captured	standing	pages 142, 253
Other	adult	125 mg	IV	not captured	standing	pages 134, 253
Other	peds	10 mg	IV/IO	not captured	standing	page 286
Other	peds	13 mg	IV/IO	not captured	standing	page 286
Other	peds	17 mg	IV/IO	not captured	standing	page 287
Other	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 142, 253
Other	peds	2 mg/kg	IV	not captured	standing	pages 134, 253
Other	peds	2 mg/kg	IO/IM	not captured	standing	pages 134, 253
Other	peds	2 mg/kg	IO/IM/PO	not captured	standing	pages 143, 253
Other	peds	2 mg/kg	IO/IM/PO	not captured	standing	page 253
Other	peds	2 mg/kg	IV/IO/IM/PO	not captured	standing	page 253
Other	peds	2 mg/kg	IV/IO/IM/PO	not captured	standing	page 253
Other	peds	21 mg	IV/IO	not captured	standing	page 287
Other	peds	26 mg	IV/IO	not captured	standing	page 288
Other	peds	33 mg	IV/IO	not captured	standing	page 288
Other	peds	42 mg	IV/IO	not captured	standing	page 289
Other	peds	53 mg	IV/IO	not captured	standing	page 289
Other	peds	6 mg	IV/IO	not captured	standing	page 286
Other	peds	8 mg	IV/IO	not captured	standing	page 286

Metoclopramide

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	10 mg	IV	not captured	standing	page 254
Nausea / vomiting	adult	10 mg	IV/IM	not captured	standing	pages 84, 85, 254

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IV/IO	not captured	standing	page 255

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Alcohol withdrawal	adult	2.5 mg	IV/IO	not captured	standing	page 256
Alcohol withdrawal	adult	5 mg	IM/IN	not captured	standing	page 256
Other	adult	2.5 mg	IV/IO	not captured	standing	page 256
Other	adult	2.5 mg	IV/IO	not captured	standing	page 256
Other	adult	2.5 mg	IV/IO	not captured	standing	page 256
Other	adult	2.5 mg	IV/IO	not captured	standing	page 256
Other	adult	5 mg	IM/IN	not captured	standing	page 256
Other	adult	5 mg	IM/IN	not captured	standing	page 256
Other	adult	5 mg	IM/IN	not captured	standing	page 256
Other	peds	0.05–0.1 mg/kg	IV/IO	not captured	standing	page 256
Other	peds	0.05–0.1 mg/kg	IV/IO	not captured	standing	page 256
Other	peds	0.2 mg/kg	IM/IN	not captured	standing	page 256
Other	peds	0.2 mg/kg	IM/IN	not captured	standing	page 256
Other	peds	1.3 mg	IM/IN	not captured	standing	page 286
Other	peds	2 mg	IV/IO	not captured	standing	page 289
Other	peds	5 mg	IM/IN	not captured	standing	page 289
RSI induction	adult	2.5 mg	IV/IO	not captured	standing	page 256
RSI induction	adult	5 mg	IM/IN	not captured	standing	page 256
Status epilepticus	adult	2.5 mg	IV/IO	not captured	standing	page 256
Status epilepticus	adult	5 mg	IM/IN	not captured	standing	page 256
Status epilepticus	peds	0.1 mg/kg	IV/IO	not captured	standing	page 256
Status epilepticus	peds	0.2 mg/kg	IM/IN	not captured	standing	page 256

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2.5–5 mg	IV/IM	not captured	standing	page 257
Other	adult	2.5–5 mg	IV/IM	not captured	standing	page 257
Other	peds	0.05–0.1 mg/kg	IV/IM	not captured	standing	page 257
Other	peds	0.3 mg	IV/IO	not captured	standing	page 286
Other	peds	0.65 mg	IV/IO	not captured	standing	page 286
Other	peds	0.85 mg	IV/IO	not captured	standing	page 287
Other	peds	1.05 mg	IV/IO	not captured	standing	page 287
Other	peds	1.3 mg	IV/IO	not captured	standing	page 288
Other	peds	1.65 mg	IV/IO	not captured	standing	page 288
Other	peds	2.1 mg	IV/IO	not captured	standing	page 289
Other	peds	2.65 mg	IV/IO	not captured	standing	page 289
Other	peds	3.3 mg	IV/IO	not captured	standing	page 290
Mild to moderate pain	adult	2.5–5 mg	IV/IM	not captured	standing	page 257

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–2 mg	IV/IO/IM	not captured	standing	page 94
Other	peds	0.1 mg/kg	IV/IM	not captured	standing	page 258
Other	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 182, 258
Other	peds	0.3 mg	IV/IO/IN	not captured	standing	page 286
Other	peds	0.65 mg	IV/IO/IN	not captured	standing	page 286
Other	peds	0.85 mg	IV/IO/IN	not captured	standing	page 287
Other	peds	1 mg	IN	not captured	standing	page 258
Other	peds	1.05 mg	IV/IO/IN	not captured	standing	page 287
Other	peds	1.3 mg	IV/IO/IN	not captured	standing	page 288
Other	peds	1.65 mg	IV/IO/IN	not captured	standing	page 288
Other	peds	2 mg	IV/IO/IN	not captured	standing	page 289

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.4 mg	SL	not captured	standing	page 259
Other	adult	0.4 mg	SL	not captured	standing	page 259
Other	adult	0.4 mg	SL	not captured	standing	page 22

Olanzapine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	PO	not captured	standing	page 260
Other	adult	10 mg	PO	not captured	standing	pages 70, 260

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	pages 84, 85, 261
Nausea / vomiting	peds	0.15 mg/kg	IV/IM/PO	not captured	standing	pages 174, 175, 261
Nausea / vomiting	peds	1.58 mg	IV/IO/PO	not captured	standing	page 287
Nausea / vomiting	peds	1.95 mg	IV/IO/PO	not captured	standing	page 288
Nausea / vomiting	peds	2.48 mg	IV/IO/PO	not captured	standing	page 288
Nausea / vomiting	peds	3.15 mg	IV/IO/PO	not captured	standing	page 289
Nausea / vomiting	peds	4 mg	IV/IO/PO	not captured	standing	page 289
Other	adult	4 mg	IV/IM	not captured	standing	page 261
Other	adult	4 mg	PO	not captured	standing	page 261
Other	peds	0.15 mg/kg	IV/IM	not captured	standing	page 261
Other	peds	4 mg	PO	not captured	standing	page 261

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	page 262
Hypoglycemia	adult	15 g	PO	not captured	standing	page 262
Hypoglycemia	peds	7.5 g	PO	not captured	standing	page 262
Hypoglycemia	peds	7.5–18.75 g	PO	not captured	standing	page 262
Other	adult	15–37.5 g	PO	not captured	standing	page 72
Other	peds	7.5–18.75 g	PO	not captured	standing	page 166

Oxytocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 unit	IM	not captured	standing	page 264
Other	adult	10 unit	IM	not captured	standing	page 264

P–R Pralidoxime, Racemic Epinephrine, Rocuronium3

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	600 mg	IM	not captured	standing	pages 279, 365

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5 mL	NEB	not captured	standing	pages 28, 134
Other	peds	0.5 mL	NEB	not captured	standing	page 134

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1 mg/kg	IV/IO	not captured	standing	page 26

S–Z Sodium Bicarbonate, Succinylcholine, Tenecteplase, Tetracaine, Thiamine, Ticagrelor, Tranexamic Acid7

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 94, 182
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 94, 182
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 94, 96, 266
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 76, 168, 266
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 94, 266
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 114, 266
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 52, 54, 56, 266
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 94, 96, 266
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 76, 168, 266

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 26, 27

Tenecteplase

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	30 mg	IV	not captured	standing	page 285
STEMI	adult	35 mg	IV	not captured	standing	page 285
STEMI	adult	40 mg	IV	not captured	standing	page 285
STEMI	adult	45 mg	IV	not captured	standing	page 285
STEMI	adult	50 mg	IV	not captured	standing	page 285

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–2 drop	TOP	not captured	standing	page 102
Other	adult	1–2 drop	TOP	not captured	standing	page 267
Other	adult	1 drop	TOP	not captured	standing	pages 122, 204
Other	adult	1–2 drop	OPH	not captured	standing	pages 122, 267
Other	peds	1 drop	OPH	not captured	standing	pages 122, 267
Other	peds	1 drop	TOP	not captured	standing	page 267
Other	peds	1 drop	TOP	not captured	standing	pages 122, 204

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	IV/IM	not captured	standing	pages 66, 72, 73, 268

Ticagrelor

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	180 mg	PO	not captured	standing	pages 40, 269

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g	IV/IO	not captured	standing	page 270
Other	adult	1 g	IV/IO	not captured	standing	pages 214, 270
Other	adult	1 g	IV/IO	not captured	standing	pages 214, 270
Other	adult	1–2 g	IV/IO	not captured	standing	page 270
Other	adult	2 g	IV/IO	not captured	standing	page 270
Other	adult	2 g	IV/IO	not captured	standing	pages 108, 112, 118, 124, 192, 196, 200, 270
Other	adult	2 g	IV/IO	not captured	standing	pages 108, 112, 118, 124
Other	peds	15 mg/kg	IV/IO	not captured	standing	pages 192, 196, 200, 270
Other	peds	15 mg/kg	IV/IO	not captured	standing	pages 108, 112, 118, 124, 192, 196, 200, 270

Northeast Ohio Regional EMS Protocol Committee

Drugs and doses51